Route To Better IVD Commercial Opportunities Outlined In UK Roadmap
Can diagnostics industry stakeholders take advantage of a rare opportunity?
Executive Summary
The COVID-19 pandemic put disease diagnosis in the spotlight for the public and national health care systems alike. A UK report highlights how the IVD industry must capitalize on this unique moment in time.
You may also be interested in...
UK Healthtech SMEs Voice The Challenges They Face In The Market
A multi-stakeholder research and funding program led by deeptech innovation organization CPI has produced two UK medtech industry outlook reports and overseen a £7m innovation funding scheme. Training to help SMEs navigate their way through the medtech regulatory maze is another part the program, the findings of which were released to the public this month.
UK MHRA’s New And Increased Medtech Fees In Force in April
One outcome of last year’s public consultation on UK MHRA fees is a hefty uplift in charges payable by medtech manufacturers in 2023, beyond which the agency is keen to pursue a new fees and charges plan.
Philips Healthcare Doubles Down On Creating An Agile Future
After an admittedly difficult 2022 for a variety of reasons, Philips Healthcare is ready to tackle 2023 and beyond by reducing business complexities, slimming staff numbers further and crucially implementing a new value creation strategy under recently appointed CEO Roy Jakobs.